Latest Updates

19th Apr 2021
Investors ask J&J, Merck and Pfizer how public investments will be factored into access and affordability plans for COVID vaccines and medicines NEW YORK, NY, MONDAY, APRIL 19, 2021...
Read more
8th Apr 2021
Shareholder proponents seek majority votes on climate lobbying proposals at May meetings of Norfolk Southern Corp. ($NSC) and Sempra Energy ($SRE). ...
Read more
16th Mar 2021
A lifetime’s work to address the social impacts of corporate practices to be honored at ICCR’s 50th Anniversary Gala. NEW YORK, NY – TUESDAY, MARCH 16TH, 2021 - The governing board of the...
Read more
11th Feb 2021
Attack on Congress seen as wake up call for companies on the inherent risks of corporate money in politics to both business and the public interest.NEW YORK, NY, THURSDAY,...
Read more
2nd Feb 2021
TUESDAY, FEBRUARY 2, 2021 – Today the Interfaith Center on Corporate Responsibility (ICCR) and the Shareholder Rights Group made public a letter they sent to acting Chair of the SEC Allison Lee on behalf of several investor groups,...
Read more
28th Jan 2021
THURSDAY, JANUARY 28, 2021 – Today the Interfaith Center on Corporate Responsibility (ICCR), a coalition of investors representing over $US 2 trillion in assets under management that engages companies on environmental, social, and...
Read more
17th Dec 2020
Shareholder proposals at seven companies request a report on the feasibility of including paid sick leave as a standard employee benefit beyond COVID-19.NEW YORK NY, THURSDAY, DECEMBER 17TH...
Read more
17th Dec 2020
Shareholder Proposals for the 2021 Proxy Highlight Business Risks Related to Retail Giant’s Practices Around Workers, Diversity and Racial Justice, Surveillance Software and Governance Structures.FRIDAY, DECEMBER...
Read more
15th Dec 2020
Letters to 21 companies seek to learn whether they are addressing how the development and marketing of food may exacerbate adverse health outcomes during the pandemic, and further contribute to systemic racism.NEW...
Read more
1st Dec 2020
New resolutions filed by shareholders reflect concerns over potential price-gouging of COVID vaccines and therapeutics created with taxpayer dollars. NEW YORK, NY, TUESDAY, DECEMBER 1, 2020...
Read more

Pages

Sign Up for our eNewsletter

* indicates required